Dr Rebecca Moore
After graduating from Warwick University with a first class honours in Virology I went on to obtain a Wellcome Trust Ph.D from Imperial College, developing retroviruses for gene therapy. I remained at Imperial College for 2 years on a Wellcome Trust Research Fellowship investigating the effect of the APOBEC3 proteins on human foamy virus (a distant relative of HIV). I then travelled to America where I spent 3 years at the NIH investigating the interactions between the HIV-1 Vif protein and the restriction factors APOBEC3G and APOBEC3F. In 2008 I joined the Sattentau lab and have spent the last 7 years investigating the cell to cell transmission of HIV-1 from T cells to macrophages and vice versa. I have recently extended my interests to include antibody-based HIV-1 vaccine design and probing vaccine adjuvant mechanism of action. I manage the Sattentau lab and the Departmental CL-III laboratory.